Immunology and Microbiology
Caenorhabditis elegans
97%
Candida albicans
89%
Staphylococcus aureus
57%
Infectious Agent
57%
Methicillin-Resistant Staphylococcus Aureus
55%
Biofilm
54%
Galleria mellonella
49%
Candida
35%
Prevalence
34%
Cryptococcus neoformans
33%
Nematode
30%
Virulence Factor
24%
COVID-19
23%
Antimicrobial Agent
23%
Minimum Inhibitory Concentration
22%
Pathogenicity
21%
Filamentation
18%
Antifungal Activity
16%
Vancomycin-Resistant Enterococcus
15%
Macrophage
15%
Antimicrobial Activity
15%
Probiotic
14%
Enterococcus faecalis
14%
Immune Response
14%
Medline
14%
Acinetobacter Baumannii
14%
Severe Acute Respiratory Syndrome Coronavirus 2
14%
Penicillium marneffei
13%
Peptoclostridium difficile
13%
Enterococcus faecium
12%
Innate Immune System
12%
Wild Type
12%
Influenza
11%
Mortality Rate
11%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
11%
Immunity
11%
Antimicrobial Peptides
11%
Quorum Sensing
11%
Hematopoietic Stem Cell Transplantation
11%
Human immunodeficiency virus
11%
Photodynamics
11%
Host Immune Response
11%
Bacterial Membrane
10%
Hypha
10%
Blood Plasma
9%
Fungal Pathogenesis
9%
Lipid Bilayer
9%
Colony-Forming Unit
9%
Colony Forming Unit S
9%
Magnetism
8%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Antiinfective Agent
65%
Staphylococcus aureus
57%
Caenorhabditis elegans
44%
Diseases
41%
Methicillin-Resistant Staphylococcus Aureus
37%
Bloodstream Infection
33%
Candida albicans
32%
Candida
30%
Antibiotics
28%
Antimicrobial Agent
28%
Prevalence
26%
SARS Coronavirus
25%
Placebo
21%
HIV
21%
Infectious Agent
21%
Antifungal Agent
20%
Clinical Trial
19%
Drug Discovery
18%
Randomized Controlled Trial
17%
Candidemia
17%
Coronavirinae
16%
Candidiasis
15%
Galleria mellonella
15%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
14%
Cohort Study
14%
Antimicrobial Resistance
13%
Meticillin
13%
Mortality Rate
12%
Antifungal Activity
12%
Remdesivir
11%
Gentamicin
11%
Antifungal Therapy
11%
Mycosis
11%
Vancomycin
11%
Comorbidity
11%
Ebola Virus Disease
10%
Clostridium Difficile Infection
10%
Invasive Aspergillosis
10%
Monoclonal Antibody
9%
Nematode
9%
Virus Infection
9%
Photodynamic Therapy
9%
Antibacterial Activity
9%
Adverse Event
8%
Enterococcus faecium
8%
Polypeptide Antibiotic Agent
8%
Caffeic Acid Phenethyl Ester
8%
Urinary Tract Infection
8%
High-Throughput Screening
8%
Keyphrases
Meta-analysis
72%
Confidence Interval
59%
Systematic Meta-analysis
43%
COVID-19
23%
Hospitalized Patients
16%
Caenorhabditis Elegans
15%
Vancomycin-resistant Enterococci
14%
Infection Risk
13%
Bloodstream Infection
13%
Odds Ratio
13%
Risk Ratio
12%
Model Host
11%
Methicillin-resistant Staphylococcus Aureus
11%
Patients with COVID-19
10%
Staphylococcus Aureus
10%
Galleria Mellonella
10%
Solid Organ Transplant Recipients
8%
Enterococcus Faecalis
8%
Cumulative Incidence
8%
Embase
8%
PubMed
8%
AIDS/HIV
7%
Staphylococcus Aureus Colonization
7%
Dialysis Patients
7%
Extended-spectrum beta-lactamase-producing Enterobacteriaceae
7%
Clostridium Difficile Infection
7%
Hospitalization
7%
Candida Albicans (C. albicans)
7%
C.albicans
7%
Retrospective Cohort Study
7%
Clinical Outcomes
7%
Short Course
7%
Antimicrobial Activity
7%
Pneumonia
7%
Risk Factors
6%
Invasive Aspergillosis
6%
Mammalian Models
6%
Long-course
6%
Bacteremia
6%
Clinical Cure
6%
Antifungal Drug Discovery
6%
Invertebrate Model
6%
Auranofin
6%
Virulence
6%
Amphotericin B
5%
Antifungal Compounds
5%
Cryptococcal Meningitis
5%
Antifungal Agents
5%
Antimicrobial
5%
Candida
5%